Influence of matching for HLA-DR in first cadaveric renal transplantation in nonsensitized recipients.
Reisaeter
A V
AV
Institute of Transplantation Immunology, Medical Department B, National Hospital, Oslo, Norway.
Leivestad
T
T
Fauchald
P
P
Brekke
I
I
Thorsby
E
E
D002102:Cadaver; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000453:epidemiology / Q000628:therapy; D006085:Graft Survival / Q000276:immunology*; D015234:HLA-A Antigens / Q000276:immunology; D015235:HLA-B Antigens / Q000276:immunology; D006684:HLA-DR Antigens / Q000276:immunology*; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology*; D014019:Tissue Donors
D015234:HLA-A Antigens; D015235:HLA-B Antigens; D006684:HLA-DR Antigens; D007166:Immunosuppressive Agents